Effects of hPTH(1-34) infusion on circulating serum phosphate, 1,25-dihydroxyvitamin D, and FGF23 levels in healthy men

Journal of Bone and Mineral Research

Volumn 24, Issue 10, 2009, Pages 1681-1685

  Burnett Bowie, Sherri Ann M ^a,b   Henao, Maria P ^b   Dere, Melissa E ^b   Lee, Hang ^b   Leder, Benjamin Z ^b  

^a Massachusetts General Hospital ^*  (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

1,25 dihydroxyvitamin D; Fibroblast growth factor 23; Phosphate; PTH

Indexed keywords

25 HYDROXYVITAMIN D; AMINO TERMINAL TELOPEPTIDE; CALCITRIOL; CALCIUM ION; CREATININE; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PHOSPHATE;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; VITAMIN BLOOD LEVEL;

ADULT; BONE DENSITY CONSERVATION AGENTS; CALCIUM; COLLAGEN TYPE I; FIBROBLAST GROWTH FACTORS; HEALTH; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PEPTIDES; PHOSPHATES; TERIPARATIDE; VITAMIN D; YOUNG ADULT;

EID: 70349934206     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.090406     Document Type: Article

References (28)

1. Shimada T 2001 Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500-6505. (Pubitemid 32488266)
2. Quarles LD 2003 Evidence for a bone-kidney axis regulating phosphate homeostasis. J Clin Invest 112:642-646.
3. ADHR Consortium 2000 Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23. Nat Genet 26:345-348.
4. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H 2003 Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656-1663. (Pubitemid 36459471)
5. Collins MT, Lindsay JR, Jain A, Kelly MH, Cutler CM, Weinstein LS, Liu J, Fedarko NS, Winer KK 2005 Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D. J Bone Miner Res 20:1944-1950. (Pubitemid 41532780)
6. Burnett-Bowie SM, Mendoza N, Leder BZ 2007 Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in men. Bone 40:913-918. (Pubitemid 46394616)
7. Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB 2003 Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64:2272-2279. (Pubitemid 37449564)
8. Ferrari SL, Bonjour JP, Rizzoli R 2005 Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90:1519-1524. (Pubitemid 40464013)
9. Burnett SM, Gunawardene SC, Bringhurst FR, Juppner H, Lee H, Finkelstein JS 2006 Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 21:1187-1196. (Pubitemid 44128331)
10. Gupta A, Winer K, Econs MJ, Marx SJ, Collins MT 2004 FGF-23 is elevated by chronic hyperphosphatemia. J Clin Endocrinol Metab 89:4489-4492.
11. Yamashita H, Yamashita T, Miyamoto M, Shigematsu T, Kazama JJ, Shimada T, Yamazaki Y, Fukumoto S, Fukagaw M, Noguchi S 2004 Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism. Eur J Endocrinol 151:55-60. (Pubitemid 39117364)
12. Tebben PJ, Singh RJ, Clarke BL, Kumar R 2004 Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism. Mayo Clin Proc 79:1508-1513. (Pubitemid 39578874)
13. Kobayashi K, Imanishi Y, Miyauchi A, Onoda N, Kawata T, Tahara H, Goto H, Miki T, Ishimura E, Sugimoto T, Ishikawa T, Inaba M, Nishizawa Y 2006 Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. Eur J Endocrinol 154:93-99. (Pubitemid 43250742)
14. Kawata T, Imanishi Y, Kobayashi K, Miki T, Arnold A, Inaba M, Nishizawa Y 2007 Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism. J Am Soc Nephrol 18:2683-2688. (Pubitemid 47531195)
15. Lee H, Finkelstein JS, Miller M, Comeaux SJ, Cohen RI, Leder BZ 2006 Effects of selective testosterone and estradiol withdrawal on skeletal sensitivity to parathyroid hormone in men. J Clin Endocrinol Metab 91:1069-1075. (Pubitemid 43357782)
16. Leder BZ, Smith MR, Fallon MA, Lee ML, Finkelstein JS 2001 Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men. J Clin Endocrinol Metab 86:511-516.
17. Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S 2002 Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 87:4957-4960. (Pubitemid 35316332)
18. Horwitz MJ, Tedesco MB, Sereika SM, Hollis BW, Garcia-Ocana A, Stewart AF 2003 Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers. J Clin Endocrinol Metab 88:1603-1609.
19. Slovik DM, Adams JS, Neer RM, Holick MF, Potts JT Jr 1981 Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med 305:372-374.
20. Nishida Y, Taketani Y, Yamanaka-Okumura H, Imamura F, Taniguchi A, Sato T, Shuto E, Nashiki K, Arai H, Yamamoto H, Takeda E 2006 Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int 70:2141-2147. (Pubitemid 44871378)
21. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T 2004 FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429-435. (Pubitemid 38787398)
22. Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro OM, Mohammadi M, Sirkis R, Naveh-Many T, Silver J 2007 The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117:4003-4008. (Pubitemid 350224109)
23. Krajisnik T, Bjorklund P, Marsell R, Ljunggren O, Akerstrom G, Jonsson KB, Westin G, Larsson TE 2007 Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 195:125-131. (Pubitemid 350056006)
24. Antoniucci DM, Yamashita T, Portale AA 2006 Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 91:3144-3149. (Pubitemid 44271770)
25. Perwad F, Azam N, Zhang MY, Yamashita T, Tenenhouse HS, Portale AA 2005 Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin d metabolism in mice. Endocrinology 146:5358-5364. (Pubitemid 41653049)
26. Ito M, Sakai Y, Furumoto M, Segawa H, Haito S, Yamanaka S, Nakamura R, Kuwahata M, Miyamoto K 2005 Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells. Am J Physiol Endocrinol Metab 288:E1101-E1109. (Pubitemid 40726796)
27. Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, Kato S, Ogata E, Segawa H, Miyamoto K, Fukushima N 2005 Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 280:2543-2549. (Pubitemid 40189356)
28. Isakova T, Gutierrez O, Shah A, Castaldo L, Holmes J, Lee H, Wolf M 2008 Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol 19:615-623. (Pubitemid 351355405)